openPR Logo
Press release

Vaccines Market Estimated to be Worth $71.50 Billion in 2031

02-24-2025 10:35 AM CET | Health & Medicine

Press release from: Meticulous Research®

Vaccines Market Estimated to be Worth $71.50 Billion in 2031

Meticulous Research®- a leading global market research company, published a research report titled 'Vaccines Market Size, Share, Forecast, & Trends Analysis by Indication (Pneumococcal, Influenza, HPV, DTP, MMR, Hepatitis, COVID-19) Administration (IM, SC, Oral) Type (Inactivated, Combination) Valence (Multivalent, Monovalent) - Global Forecast to 2031.'

According to this latest publication from Meticulous Research®, the vaccines market is projected to reach $71.50 billion by 2031, at a CAGR of 2.3% during the forecast period. This market's growth is driven by a strong pipeline for vaccines, increasing government initiatives toward immunization, and technological advancements in the vaccine industry. Moreover, the rising prevalence of diseases, growing focus on therapeutic vaccines, and growth prospects in emerging markets are expected to offer growth opportunities for the players operating in this market.
However, the high costs involved in vaccine development and the long timelines of vaccine manufacturing restrain the market's growth. Additionally, product recalls and inadequate access to vaccines pose challenges to the market's growth.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5076

Key Players
The key players operating in the vaccines market are Sanofi (France), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Daiichi Sankyo Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), and AstraZeneca PLC (U.K.).

Vaccines Market: Future Outlook
The vaccines market is segmented based on Indication (Pneumococcal Disease, Influenza, Human Papillomavirus (HPV), Diphtheria, Tetanus, and Pertussis (DTP), Meningococcal Disease, Measles, Mumps, and Rubella (MMR), Rotavirus, Poliomyelitis (Polio), Hepatitis, COVID-19, Other Indications), Route of Administration (Intramuscular, Subcutaneous, Oral, Other Route of Administration), Type (Subunit & Conjugate Vaccines, Inactivated Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, Combination Vaccines), and Valence (Multivalent and Monovalent Vaccines) and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.

Based on indication, the vaccines market is segmented into pneumococcal disease, influenza, human papillomavirus (HPV), diphtheria, tetanus, pertussis (DTP), meningococcal disease, measles, mumps, rubella (MMR), rotavirus, poliomyelitis (polio), hepatitis, COVID-19, and other indications. In 2024, the pneumococcal disease segment is expected to account for the largest share of the vaccines market. The large market share of this segment can be attributed to the rising incidence of pneumococcal diseases such as pneumonia, meningitis, febrile bacteremia, otitis media, and sinusitis; and the development of quality vaccines such as PPSV23.

Based on route of administration, the vaccines market is segmented into intramuscular (IM), subcutaneous (SC), oral, and other routes of administration. In 2024, the intramuscular (IM) segment is expected to account for the largest share of the vaccines market. The large market share of this segment can be attributed to the ease of intramuscular administration and quick absorption of vaccines administered through the intramuscular route. Further, due to the COVID-19 pandemic, there has been increased adoption of the intramuscular route of administration, as many COVID-19 vaccines are being administered through this route.

Based on type, the vaccines market is segmented into subunit & conjugate vaccines, inactivated vaccines, live-attenuated vaccines, toxoid vaccines, and combination vaccines. In 2024, the subunit & conjugate vaccines segment is expected to account for the largest share of the vaccines market. The large market share of this segment can be attributed to the subunit & conjugate vaccines' long-term immunity, high safety, and stability compared to vaccines with other antigens.

Buy the Complete Report with an Impressive Discount: https://www.meticulousresearch.com/Checkout/94492906

Based on valence, the vaccines market is segmented into multivalent vaccines and monovalent vaccines. In 2024, the multivalent vaccines segment is expected to account for the larger share of the vaccines market. The large market share of this segment can be attributed to the launch of newer multivalent vaccines, increasing investments by key players in the R&D of multivalent vaccines, and technological advancements in the production of multivalent vaccines.

Geographic Review
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East & Africa. In 2024, North America is estimated to account for the largest share of 41.2% of the vaccines market, followed by Europe and Asia-Pacific. North America's major market share is attributed to the growing research & development, product launches, and the establishment of new facilities in the region by key players.

Complete Report Here : https://www.meticulousresearch.com/product/vaccines-market-5076

Key Questions Answered in the Report:
• Which high-growth market segments are in terms of indication, route of administration, type, valence, and regions/countries?
• What was the historical market for vaccines across the globe?
• What are the market forecasts and estimates for the period 2024-2031?
• What are the major drivers, restraints, challenges, and opportunities in the vaccines market?
• What is the competitive landscape like, and who are the market leaders in the vaccines market?
• What are the recent developments in the vaccines market?
• What strategies are adopted by the major players in the vaccines market?
• What are the geographical trends and high-growth regions/countries?

Related Reports:

Anesthesia Machines Market: https://www.meticulousresearch.com/product/anesthesia-machines-market-5533

Veterinary Vaccines Market: https://www.meticulousresearch.com/product/veterinary-vaccines-market-5618

Viral Vaccines Market : https://www.meticulousresearch.com/product/viral-vaccines-market-5920

Vaccine Storage Equipment Market: https://www.meticulousresearch.com/product/vaccine-storage-equipment-market-5160

About Us:

We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with actionable market intelligence tailored to drive revenue transformation and strategic growth. Our insights reveal forward-looking revenue opportunities, providing our clients with a competitive edge through a diverse suite of research solutions-syndicated reports, custom research, and direct analyst engagement.

Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight key industry sectors and 20+ geographic markets. With a focus on solving the complex challenges facing global business leaders, our research enables informed decision-making that propels sustainable growth and operational excellence. We are dedicated to delivering high-impact solutions that transform business performance and fuel innovation in the competitive global marketplace.

Contact Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email- sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn- https://www.linkedin.com/company/meticulous-research
Meticulous Blog | Top Market Research Reports Blog - https://meticulousblog.org/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccines Market Estimated to be Worth $71.50 Billion in 2031 here

News-ID: 3882260 • Views:

More Releases from Meticulous Research®

Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Introduction The global Direct Air Capture (DAC) market has entered a period of rapid transformation as nations, industries, and corporations intensify their efforts to achieve net-zero emissions. Valued at $136.5 million in 2024, the market is projected to grow significantly, reaching approximately $6.93 billion by 2035. This expansion, driven by a remarkable compound annual growth rate (CAGR) of 43.3% between 2025 and 2035, highlights the growing importance of DAC technologies in
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
Introduction The European direct-to-consumer (DTC) genetic testing market is expanding at a remarkable pace, reflecting rising consumer interest in personalized healthcare and genetic insights. Valued at $464 million in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 23.3%, reaching nearly $3.78 billion by 2035. This growth underscores how advances in genomic sequencing, combined with increasing health awareness, are reshaping the healthcare and wellness landscape
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Introduction The global peer-to-peer (P2P) energy trading platforms market is undergoing rapid transformation as new technologies reshape how energy is generated, distributed, and traded. Valued at $138 million in 2024, the market is projected to grow significantly, reaching nearly $2.34 billion by 2035. This growth, at a compound annual growth rate (CAGR) of 29.7% from 2025 to 2035, highlights the increasing adoption of decentralized energy solutions and digital platforms that empower
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Introduction The global dermoscopy and skin visualization devices market is entering a phase of rapid transformation, driven by the increasing need for early detection of skin conditions and the rising incidence of skin cancer worldwide. Valued at $1.33 billion in 2024, the market is expected to reach nearly $3.3 billion by 2035, expanding from an estimated $1.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.7% during the

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion